Contribute
España
Italia
대한민국
日本
Français

Benzinga

Research
My Stocks
Tools
Free Benzinga Pro Trial

Top Stories

EXCLUSIVE: Draganfly Secures Major IACLEA Win To Expand Campus Drone Programs Nationwide
EXCLUSIVE: Draganfly Secures Major IACLEA Win To Expand Campus Drone Programs Nationwide
Corteva Shares Rise Following Landmark Supreme Court Pesticide Ruling
Corteva Shares Rise Following Landmark Supreme Court Pesticide Ruling
Micron Just Gave AI Investors Exactly What They Wanted
Micron Just Gave AI Investors Exactly What They Wanted
Corteva Shares Rise Following Landmark Supreme Court Pesticide Ruling
Corteva Shares Rise Following Landmark Supreme Court Pesticide Ruling
Micron Just Gave AI Investors Exactly What They Wanted
Micron Just Gave AI Investors Exactly What They Wanted
Chasing The AI Supercycle: Defiance Rolls Out ETFs Targeting Semiconductors Over Software
Chasing The AI Supercycle: Defiance Rolls Out ETFs Targeting Semiconductors Over Software
If You Invested $1,000 In Micron Stock At IPO, Here’s How Much You’d Have Today
If You Invested $1,000 In Micron Stock At IPO, Here’s How Much You’d Have Today

Top Stories Recent News

Why Is Redwire Stock Falling On Thursday?
Why Is Redwire Stock Falling On Thursday?
Redwire (RDW) stock falls 8% on $500M ATM dilution fears and cooling space sector sentiment. Get the latest technical levels.
Argenx Analyst Is Bullish Despite Changes To Phase 3 Myositis Study
Argenx Analyst Is Bullish Despite Changes To Phase 3 Myositis Study
HC Wainwright sees over $1 billion in sales potential for Argenx's Vyvgart in IMNM despite myositis trial changes.
Oil Slips Below $70: Are Energy ETFs Heading For A Reality Check?
Oil Slips Below $70: Are Energy ETFs Heading For A Reality Check?
Oil prices have fallen below $70, putting energy ETFs under stress. Here's how lower crude prices could impact performance.
ARS Pharma Reaffirms 2027 Breakeven Goal Despite Missing July Neffy Coverage Wins
ARS Pharma Reaffirms 2027 Breakeven Goal Despite Missing July Neffy Coverage Wins
ARS Pharma reaffirmed its 2027 breakeven target, cut expenses and gained Florida Medicaid access for Neffy despite coverage setbacks.
IT Services Giant TD SYNNEX Sees No Slowdown In Customer Spending Despite Rising Prices
IT Services Giant TD SYNNEX Sees No Slowdown In Customer Spending Despite Rising Prices
TD SYNNEX (SNX) crushes Q2 expectations, posting $19.58B in revenue and $4.85 EPS. Discover what drove the massive financial beat.
Kymera Therapeutics Stock Climbs On Accelerated Timeline For Lead Atopic Dermatitis Program
Kymera Therapeutics Stock Climbs On Accelerated Timeline For Lead Atopic Dermatitis Program
Kymera Therapeutics shares surged after completing KT-621 Phase 2b enrollment early, accelerating data timing and Phase 3 plans.
What's Going On With Marvell Technology Stock Thursday?
What's Going On With Marvell Technology Stock Thursday?
Marvell (MRVL) stock rides tech rally higher. Check out the latest analyst price targets, technical indicators, and CFO insider selling.
McCormick Says Healthy Eating Shift Is Creating New Growth Opportunities
McCormick Says Healthy Eating Shift Is Creating New Growth Opportunities
McCormick ($MKC) stock jumps 5%+ after Q2 revenue of $1.94B and adjusted EPS of $0.80 top Wall Street expectations. Read the full report.
Google Finance Exits Beta, Launches Portfolios, AI Tools, New Dedicated Android App
Google Finance Exits Beta, Launches Portfolios, AI Tools, New Dedicated Android App
Google Finance officially exits beta, unveiling massive global upgrades, automated portfolio dashboards, and a dedicated mobile app loaded with advanced AI research tools.
Why Is Dell Technologies Stock Falling Thursday?
Why Is Dell Technologies Stock Falling Thursday?
Dell stock drops 6% after a GF Securities downgrade over valuation concerns. Is the AI-driven rally cooling off?
Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved